Metabolic and nutritional considerations in nonalcoholic fatty liver

Hepatology

Volumn 32, Issue 1, 2000, Pages 3-10

  Fong, Derek G ^a   Nehra, Vandana ^a   Lindor, Keith D ^a   Buchman, Alan L ^b  

^a MAYO CLINIC   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERY LOW DENSITY LIPOPROTEIN;

DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY LIVER; HUMAN; JEJUNOILEAL BYPASS; KWASHIORKOR; LIPID METABOLISM; LIVER METABOLISM; OBESITY; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; REVIEW; SYNDROME X; TOTAL PARENTERAL NUTRITION;

EID: 0034235208     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.8978     Document Type: Article

References (140)

1. 1. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998;15:246-258.
2. 2. Hautekeete ML, Degott C, Benhamou JP. Microvesicular steatosis of the liver. Acta Clin Belg 1990;45:311-326.
3. 3. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 1997;26(Suppl 2):43-53.
4. 4. Fromenty B, Berson A, Pessayre D. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997;26(Suppl 1):13-22.
5. 5. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286-301.
6. 6. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-1109.
7. 7. Ludwig J, McGill DB, Lindor KD. Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997;12:398-403.
8. 8. O'Leary JP. Hepatic complications of jejunoileal bypass. Semin Liv Dis 1983;3:203-215.
9. 9. McLaren DS, Bitar JG, Nassar VH. Protein-calorie malnutrition and the liver. Prog Liv Dis 1972;4:527-536.
10. 10. Clain DJ, Lefkowitch JH. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 1987;16:239-252.
11. 11. Van Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes Relat Metab Disord 1995;19:S27-S36.
12. 12. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513-1517.
13. 13. Rofsky NM, Fleishaker H. CT and MRI of diffuse liver disease. Semin Ultrasound CT MR 1995;16:16-33.
14. 14. Zwiebel WJ. Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MR 1995;16:8-15.
15. 15. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984;8:97-106.
16. 16. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res 1997;5:542-548.
17. 17. Bellentani S, Saccocio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000;132:112-117.
18. 18. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. HEPATOLOGY 1990;11:74-80.
19. 19. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. HEPATOLOGY 1995;22:1714-1719.
20. 20. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. HEPATOLOGY 1990;11:59-64.
21. 21. Heubi JE, Partin JC, Partin JS, Schubert WK. Reye's syndrome: current concepts. HEPATOLOGY 1987;7:155-164.
22. 22. Saleh J, Sniderman AD, Cianflone K. Regulation of plasma fatty acid metabolism. Clin Chim Acta 1999;286:163-180.
23. 23. Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 1997;8:146-153.
24. th Ed. New York: W.H. Freeman, c1995.
25. 25. Carey GB. Mechanisms regulating adipocyte lipolysis. Adv Exp Med Biol 1998,441:157-170.
26. 26. Foster DW, McGarry JD. The regulation of ketogenesis. Ciba Found Symp 1982;87:120-131.
27. 27. Bjorntorp P, Bergman H, Varnauskas E. Plasma free fatty acid turnover in obesity. Acta Med Scand 1969;185:351-356.
28. 28. Gorden ES. Non-esterified fatty acids in blood of obese and lean subjects. Am J Clin Nutr 1960;8:740-747.
29. 29. Madison LL, Seyffert WA, Unger RH, Barker B. Effect of plasma free fatty acids on plasma glucagon and serum insulin concentrations. Metabolism 1968;17:301-304.
30. 30. Laws A. Free fatty acids, insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1996;7:172-177.
31. 31. Belfiore F, Iannello S. Insulin resistance in obesity: metabolic mechanisms and measurement methods. Mol Gen Metab 1998;65:121-128.
32. 32. Shepherd PR, Kahn BB. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-257.
33. 33. Chen YDI, Golay A, Swislocki ALM, Reaven GM. Resistance to insulin suppression of plasma free fatty acids concentrations and insulin stimulation of glucose uptake in NIDDM. J Clin Endocrinol Metab 1987;64:17-21.
34. 34. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liv Dis 1986;8:283-298.
35. 35. Stone BG, Van Thiel DH. Diabetes mellitus and the liver. Semin Liv Dis 1985;5:8-28.
36. 36. Posner I, DeSanctis J. Kinetics of product inhibition and mechanisms of lipoprotein lipase activation by apolipoprotein C-II. Biochemistry 1987;26:3711-3717.
37. 37. Saxena U, Witte LD, Goldberg IJ. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 1989;264:4349-4355.
38. 38. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989;320:1060-1068.
39. 39. Mason TM. The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes. Crit Rev Clin Lab Sci 1998;35:461-487.
40. 40. Lewis GF, Steiner G. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care 1996;19:390-393.
41. 41. Oehler G, Bleyl H, Matthes KJ. Hyperinsulinemia in hepatic steatosis. Int J Obes 1982;6(Suppl 1):137-144.
42. 42. Wanless IR, Bargman JM, Oreopoulos DG, Vas SI. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 1989;2:69-74.
43. 43. Guzman M, Geelen MJ. Regulation of fatty acid oxidation in mammalian liver. Biochim Biophys Acta 1993;1167:227-241.
44. 44. Beynen AC, Vaartjes WJ, Geelen MJ. Opposite effects of insulin and glucagon in acute hormonal control of hepatic lipogenesis. Diabetes 1979;28:828-835.
45. 45. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-845.
46. 46. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? HEPATOLOGY 1998;27:1463-1466.
47. 47. James WP, Coore HG. Persistent impairment of insulin secretion and glucose tolerance after malnutrition. Am J Clin Nutr 1970;23:386-389.
48. 48. Alleyne GA, Trust PM, Flores H, Robinson H. Glucose tolerance and insulin sensitivity in malnourished children. Br J Nutr 1972;27:585-592.
49. 49. Smith SR, Edgar PJ, Pozefsky T, Chhetri MK, Prout TE. Insulin secretion and glucose tolerance in adults with protein-calorie malnutrition. Metabolism 1975;24:1073-1084.
50. 50. Hadden DR. Glucose, free fatty acid, and insulin interrelations in kwashiorkor and marasmus. Lancet 1967;2:589-592.
51. 51. Milner RD. Insulin secretion in human protein-calorie deficiency. Proc Nutr Soc 1972;31:219-223.
52. 52. Sims EA, Horton ES. Endocrine and metabolic adaptation to obesity and starvation. Am J Clin Nutr 1968;21:1455-1470.
53. 53. Klein CJ, Stanek GS, Wiles CE 3rd. Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc 1998;98: 795-806.
54. 54. Delzenne NM, Hernaux NA, Taper HS. A new model of acute liver steatosis induced in rats by fasting followed by refeeding a high carbohydrate-fat free diet. Biochemical and morphological analysis. J Hepatol 1997;26:880-885.
55. 55. Acheson KJ, Schutz Y, Bessard T, Ravussin E, Jequier E, Flatt JP. Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal. Am J Physiol 1984;246(1 Pt 1):E62-E70.
56. 56. Iritani N, Nishimoto N, Katsurada A, Fukuda H. Regulation of hepatic lipogenic enzyme gene expression by diet quantity in rats fed a fat-free, high carbohydrate diet. J Nutr 1992;122:28-36.
57. 57. Kim TS, Freake HC. High carbohydrate diet and starvation regulate lipogenic mRNA in rats in a tissue-specific manner. J Nutr 1996;126:611-617.
58. 58. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. Effect of sustained physiologic hyperinsulinemia and hyperglycemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994;37:1025-1035.
59. 59. Koopmans SJ, Ohman L, Haywood JR, Mandarino LJ, DeFronzo RA. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats. Diabetes 1997;46:1572-1578.
60. 60. Onitiri AC, Boyo AE. Serum lipids and lipoproteins in children with kwashiorkor. Br Med J 1975;3:630-631.
61. 61. Persson B, Habte D, Sterky G. Dietary effects in the early recovery phase of kwashiorkor. Plasma levels of triglycerides, FFA, D-beta-hydroxybutyrate, glycerol, postheparin lipoprotein lipase (LPL), glucose and insulin. Acta Paediatr Scand 1976;65:329-336.
62. 62. Ogunkeye OO, Ighogboja IS. Increase in total serum triglyceride and phospholipid in kwashiorkor. Ann Trop Paediatr 1992;12:463-466.
63. 63. Taylor GO. Serum triglycerides and fatty acids in kwashiorkor. Am J Clin Nutr 1971;24:1212-1215.
64. 64. Carter AL, Abney TO, Lapp DF. Biosynthesis and metabolism of carnitine. J Child Neurol 1995;10(Suppl 2):S3-S7.
65. 65. Karpati G, Carpenter S, Engel AG, Watters G, Allen J, Rothman S, Klassen G, et al. The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology 1975;25:16-24.
66. 66. Pons R, De Vivo DC. Primary and secondary carnitine deficiency syndromes. J Child Neurol 1995;10(Suppl 2):S8-S24.
67. 67. Hammond KD, Tobiansky R, Abrahams OL. Serum carnitine in children with kwashiorkor. Ann Trop Paediatr 1987;7:214-216.
68. 68. Naismith DJ. Kwashiorkor in western Nigeria: a study of traditional weaning foods, with particular reference to energy and linoleic acid. Br J Nutr 1973;30:567-576.
69. 69. Holman RT, Johnson SB, Mercuri O, Itarte HJ, Rodrigo MA, De Tomas ME. Essential fatty acid deficiency in malnourished children. Am J Clin Nutr 1981;34:1534-1539.
70. 70. Franco VH, Hotta JK, Jorge SM, dos Santos JE. Plasma fatty acids in children with grade III protein-energy malnutrition in its different clinical forms: marasmus, marasmic kwashiorkor, and kwashiorkor. J Trop Pediatr 1999;45:71-75.
71. 71. Rivers JP, Frankel TL. Essential fatty acid deficiency. Br Med Bull 1981;37:59-64.
72. 72. Sherman CD Jr, May AG, Nye W. Waterhouse C. Clinical and metabolic studies following bowel by-passing for obesity. Ann N Y Acad Sci 1965;131:614-622.
73. 73. Hocking MP, Davis GL, Franzini DA, Woodward ER. Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci 1998;43:2493-2499.
74. 74. Halverson JD. Metabolic risk of obesity surgery and long-term follow-up. Am J Clin Nutr 1992;55:602S-605S.
75. 75. O'Leary JP. Hepatic complications of jejunoileal bypass. Semin Liv Dis 1983;3:203-215.
76. 76. Halverson JD. Vitamin and mineral deficiencies following obesity surgery. Gastroenterol Clin North Am 1987;16:307-315.
77. 77. Shizgal HM, Forse RA, Spanier AH, MacLean ED. Protein malnutrition following intestinal bypass for morbid obesity. Surgery 1979;86:60-69.
78. 78. Moxley RT 3d, Pozefsky T, Lockwood DH. Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Eng J Med 1974;290:921-926.
79. 79. Frohlich J, Hahn P, Cleator I. Changes in plasma carnitine levels after jejunoileal bypass. Lancet 1980;1:1085.
80. 80. Solhaug JH, Grundt I. Metabolic changes after jejuno-ileal bypass for obesity. Scand J Gastroenterol 1978;13:169-175.
81. 81. Miyajima H, Sakamoto M, Oikawa T, Honjou H, Kanaoka S, Honda N. Carnitine deficiency following massive intestinal resection: a morphological and biochemical study. Jpn J Med 1990;29:95-98.
82. 82. Heimburger SL, Steiger E, Lo Gerfo P, Biehl AG, Williams MJ. Reversal of severe fatty hepatic infiltration after intestinal bypass for morbid obesity by calorie-free amino acid infusion. Am J Surg 1975;129:229-235.
83. 83. Lockwood DH, Amatruda JM, Moxley RT, Pozefsky T, Boitnott JK. Effect of oral amino acid supplementation on liver disease after jejunoileal bypass for morbid obesity. Am J Clin Nutr 1977;30:58-63.
84. 84. Seccombe D, Burget D, Frohlich J, Hahn P, Cleator I, Gourlay RH. Oral L-carnitine administration after jejunoileal by-pass surgery. Int J Obes 1984;8:427-433.
85. 85. Bosello O, Armellini F, Pelloso M, Ostuzzi R, Ottolenghi A, Scuro LA. Glucose tolerance in jejunoileal bypass for morbid obesity: a fifteen month follow-up. Diabete Metab 1978;4:159-162.
86. 86. Ackerman NB. Observations on the improvements in carbohydrate metabolism in diabetic and other morbidly obese patients after jejunoileal bypass. Surg Gynecol Obstet 1981;152:581-586.
87. 87. Rehfeld JF, Juhl E, Quaade F. Effect of jejunoileostomy on glucose and insulin metabolism in ten obese patients. Metabolism 1970;19:529-538.
88. 88. Sorensen TI, Lauritsen KB, Holst JJ, Stadil F, Andersen B. Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Digestion 1983;26:137-145.
89. 89. Sarson DE, Scopinaro N, Bloom SR. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 1981;5:471-480.
90. 90. Naslund E, Backman L, Holst JJ, Theodorsson E, Hellstrom PM. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 1998;8:253-260.
91. 91. Whitlow K, Cleator I, Frohlich J. Changes in plasma lipids after jejunoileal bypass. CMAJ 1981;124:298-300.
92. 92. Buchwald H, Rucker RD, Schwartz MZ, Varco RL. Positive results of jejunoileal bypass surgery: emphasis on lipids with comparison to gastric bypass. Int J Obes 1981;5:399-404.
93. 93. Scott HW Jr, Dean RH, LeQuire V, Swift LL, Younger RK, Butts WH. Alterations in plasma lipid concentrations in normal and hyperlipidemic patients with morbid obesity before and after jejunoileal bypass. Am J Surg 1978;135:341-347.
94. 94. Bendezu R, Wieland RG, Green SG, Hallberg MC, Marsters RW. Certain metabolic consequences of jejunoileal bypass. Am J Clin Nutr 1976;29: 366-370.
95. 95. Fleming CR. Hepatobiliary complications in adults receiving nutrition support. Dig Dis 1994;12:191-198.
96. 96. Payne-James JJ, Silk DB. Hepatobiliary dysfunction associated with total parenteral nutrition. Dig Dis 1991;9:106-124.
97. 97. Tulikoura I, Huikuri K. Morphological fatty changes and function of the liver, serum free fatty acids, and triglycerides during parenteral nutrition. Scand J Gastroenterol 1982;17:177-185.
98. 98. Sax HC, Talamini MA, Brackett K, Fischer JE. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels. Surgery 1986;100:697-704.
99. 99. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 1980;79:131-137.
100. 100. Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill DB. Does long-term home parenteral nutrition in adult patients cause chronic liver disease? JPEN: J Parenter Enteral Nutr 1985;9:11-17.
101. 101. Campos AC, Oler A, Meguid MM, Chen TY. Liver biochemical and histological changes with graded amounts of total parenteral nutrition. Arch Surg 1990;125:447-450.
102. 102. Sheldon GF, Peterson SR, Sanders R. Hepatic dysfunction during hyperalimentation. Arch Surg 1978;113:504-508.
103. 103. Meguid MM, Chen TY, Yang ZJ, Campos AC, Hitch DC, Gleason JR. Effects of continuous graded total parenteral nutrition on feeding indexes and metabolic concomitants in rats. Am J Physiol 1990;260(1 Pt 1):E126-E140.
104. 104. Vigili de Kreutzenberg S, Lisato G, Riccio A, Giunta F, Bonato R, Petolillo M, Tiengo A, et al. Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. Metabolism 1988;37: 510-513.
105. 105. Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery 1980;88:93-100.
106. 106. Li S, Nussbaum MS, Teague D, Gapen CL, Dayal R, Fischer JE. Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res 1988;44:639-648.
107. 107. Li SJ, Nussbaum MS, McFadden DW, Gapen CL, Dayal R, Fischer JE. Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats. Surgery 1988; 104:350-357.
108. 108. Li SJ, Nussbaum MS, McFadden DW, Zhang FS, LaFrance RJ, Dayal R, Fischer JE. Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats. J Surg Res 1990;48:421-426.
109. 109. Buzby GP, Mullen JL, Stein TP, Rosato EF. Manipulation of TPN caloric substrate and fatty infiltration of liver. J Surg Res 1981;31:46-54.
110. 110. Meguid MM, Akahoshi MP, Jeffers S, Hayashi RJ, Hammond WG. Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study. Arch Surg 1984;119: 1294-1298.
111. 111. Nussbaum MS, Li S, Bower RH, McFadden DW, Dayal R, Fischer JE. Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin/glucagon ratio. JPEN: J Parenter Enteral Nutr 1992;16:106-109.
112. 112. Reif S, Tano M, Oliverio R, Young C, Rossi T. Total parenteral nutrition-induced steatosis: reversal by parenteral lipid infusion. JPEN: J Parenter Enteral Nutr 1991;15:102-104.
113. 113. Hall RI, Grant JR, Ross LH, Coleman RA, Bozovic MG, Quarfordt SH. Pathogenesis of hepatic steatosis in the parenterally fed rat. J Clin Invest 1984;74:1658-1668.
114. 114. Kollef MH, McCormack MT, Caras WE, Reddy VV, Bacon D. The fat overload syndrome: successful treatment with plasma exchange. Ann Int Med 1990;112:545-546.
115. 115. Haber LM, Hawkins EP, Seilheimer DK, Saleem A. Fat overload syndrome. An autopsy study with evaluation of the coagulopathy. Am J Clin Pathol 1988;90:223-227.
116. 116. Heyman MB, Storch S, Ament ME. The fat overload syndrome. Report of a case and literature review. Am J Dis Childr 1981;135:628-630.
117. 117. Berner YN, Larchian WA, Lowry SF, Nicroa RR, Brennan MF, Shike M. Low plasma carnitine in patients on prolonged total parenteral nutrition: association with low plasma lysine. JPEN: J Parenter Enteral Nutr 1990;14:255-258.
118. 118. Bowyer BA, Fleming CR, Ilstrup D, Nelson J, Reek S, Burnes J. Plasma carnitine levels in patients receiving home parenteral nutrition. Am J Clin Nutr 1986;43:85-91.
119. 119. Pichard C, Roulet M, Schutz Y, Rossle C, Chiolero R, Temler E, Schindler C, et al. Clinical relevance of L-carnitine-supplemented total parenteral nutrition in postoperative trauma. Am J Clin Nutr 1986;49: 283-289.
120. 120. Tao RC, Yoshimura NN. Carnitine metabolism and its application in parenteral nutrition. JPEN: J Parenter Enteral Nutr 1980;4:469-486.
121. 121. Bowyer BA, Fleming CR, Haymond MW, Miles JM. L-carnitine: effect of intravenous administration on fuel homeostasis in normal subjects and home-parenteral-nutrition patients with low plasma carnitine concentrations. Am J Clin Nutr 1989;49:618-623.
122. 122. Palombo JD, Schnure F, Bistrian BR, Buchanan LM, Blackburn GL. Improvement of liver function tests by administration of L-carnitine to a carnitine-deficient patient receiving home parenteral nutrition: a case report. JPEN: J Parenteral Enteral Nutr 1987;11:88-92.
123. 123. Ahern DA, Mitchell ME. Liver function in protein-energy malnutrition measured by cinnamic acid tolerance and benzoic acid tolerance: effect of carnitine supplementation Br J Nutr 1989;61:209-221.
124. 124. Bowyer BA, Miles JM, Haymond MW, Fleming CR. L-carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentrations. Gastroenterology 1988;94:434-438.
125. 125. Sheard NF, Tayek JA, Bistrian BR, Blackburn GL, Zeisel SH. Plasma choline concentration in humans fed parenterally. Am J Clin Nutr 1986;43:219-224.
126. 126. Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 1992;102(4 Pt 1):1363-1370.
127. 127. Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J, et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. HEPATOLOGY 1995;22:1399-1403.
128. 128. Zeisel SH, Blusztajn JK. Choline and human nutrition. Ann Rev Nutr 1994;14:269-296.
129. 129. Lombardi B, Pani P, Schlunk FF. Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lip Res 1968;9:437-446.
130. 130. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988;263:2998-3004.
131. 131. Yao ZM, Vance DE. Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem Cell Biol 1990;68:552-558.
132. 132. Connor WE. Editorial: Pathogenesis and frequency of essential fatty acid deficiency during total parenteral nutrition. Ann Int Med 1975;83: 895-896.
133. 133. Fleming CR, Smith LM, Hodges RE. Essential fatty acid deficiency in adults receiving total parenteral nutrition. Am J Clin Nutr 1976;29:976-983.
134. 134. Goodgame JT, Lowry SF Brennan MF. Essential fatty acid deficiency in total parenteral nutrition: time course of development and suggestions for therapy. Surgery 1978;84:271-277.
135. 135. Barr LH, Dunn GD, Brennan MF. Essential fatty acid deficiency during total parenteral nutrition. Ann Surg 1981;193:304-311.
136. 136. Richardson TJ, Sgoutas D. Essential fatty acid deficiency in four adult patients during total parenteral nutrition. Am J Clin Nutr 1975;28:258-263.
137. 137. Helton WS, Smith RJ, Rounds J, Wilmore DW. Glutamine prevents pancreatic atrophy and fatty liver during elemental feeding. J Surg Res 1990;48:297-303.
138. 138. Yeh SL, Chen WJ, Huang PC. Effect of L-glutamine on hepatic lipids at different energy levels in rats receiving total parenteral nutrition. JPEN: J Parenteral Enteral Nutr 1994;18:40-44.
139. 139. Furst P, Albers S, Stehle P. Evidence for a nutritional need for glutamine in catabolic patients. Kidney Int 1989;27:S287-S292.
140. 140. Furst P, Pogan K, Stehle P. Glutamine dipeptides in clinical nutrition. Nutrition 1997;13:731-737.